Bluesight Appoints Jason Vander Meer as Chief Product Officer to Expand Medication Intelligence Suite New leader of product strategy and development to drive innovation, support company’s growth plans ALEXANDRIA, Va., Oct. 26, 2023 — Bluesight, the leader in...
Kalderos names veteran healthcare leader Angie Franks as new CEORedefining how the business of healthcare performs.™ (PRNewsfoto/Kalderos) Experienced chief executive brings growth mindset,strong vision to Drug Discount Management solution leader CHICAGO, Sept. 20,...
Deciphera Pharmaceuticals Announces Positive Top-line Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) and Updated Results from Phase 1/2 Study of Vimseltinib in TGCT – MOTION Study Met Primary Endpoint...
Lilly Completes Acquisition of DICE Therapeutics INDIANAPOLIS, Aug. 9, 2023 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of DICE Therapeutics, Inc. (NASDAQ: DICE). The acquisition expands...
PASSAGE BIO ANNOUNCES PROMISING INTERIM CLINICAL DATA FROM FIRST EIGHT PATIENTS WITH GM1 GANGLIOSIDOSIS IN IMAGINE-1 STUDY Interim safety data up to 28 months showed Dose 1 and 2 of PBGM01 were well tolerated and had a favorable safety and immunological profile Dose 2...
Abcuro Announces $155 Million Oversubscribed Series B Financing to Further Advance Autoimmune Pipeline Financing co-led by Redmile Group and Bain Capital Life Sciences Proceeds to support completion of Phase 2/3 registrational trial of ABC008, a first-in-class...
Recent Comments